ClinicalTrials.Veeva

Menu

LUS in Acute Heart Failure Therapeutic Adaptation (EPPICA)

Grenoble Alpes University Hospital Center (CHU) logo

Grenoble Alpes University Hospital Center (CHU)

Status

Unknown

Conditions

Acute Heart Failure
Pulmonary Congestion

Treatments

Other: Lung ultrasound

Study type

Observational

Funder types

Other

Identifiers

NCT04633629
2020-A02413-36 (Other Identifier)
38RC20.328

Details and patient eligibility

About

Evaluate lung ultrasound aspect according to diuretics dosage evolution in patients hospitalized for acute heart failure.

Full description

EPPICA is an observational and prospective cohort study. The study goal is to evaluate LUS aspect evolution according to diuretics dosage in patients hospitalized for acute heart failure.

Enrollment

94 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Acute heart failure diagnosed by a senior physician in the medical department, with a confirmation of a second senior physician.
  • Hospitalised in the medical department.
  • No objection from the patient of his trusted person.

Exclusion criteria

  • Administrative supervision or deprived of their liberty
  • Pulmonary conditions distracting lung ultrasound (pneumonectomy, pulmonary fibrosis)
  • Chronically dialysed

Trial design

94 participants in 1 patient group

Patients with acute heart failure
Description:
Patients hospitalized for acute heart failure in medical department.
Treatment:
Other: Lung ultrasound

Trial contacts and locations

0

Loading...

Central trial contact

Perrine Dumanoir, Doctor; Mélanie Arnaud

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems